Global Antibiotics Active Pharmaceutical Ingredient (API) Market Research Report 2021

Publisher Name :
Date: 07-Apr-2021
No. of pages: 122
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Penicillin Antibiotics

- Cephalosporins

- Carbapenem Antibiotics

Segment by Application

- Pharmaceutical Companies

- Contract Manufacturing Organizations (CMOs)

- Contract Development & Manufacturing Organizations (CDMOs)

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Sandoz International

- Centrient Pharmaceuticals

- CordenPharma International

- ACS DOBFAR

- Nanjing Dorra Pharmaceutical Technology

- DAEWOONG PHARMACEUTICAL

- Parabolic Drugs

- Penam Laboratories

- ASIATIC DRUGS & PHARMACEUTICALS

- Fresenius Kabi

- The United Laboratories International Holdings

- Aurobindo Pharma

- Unimark Remedies

- Savior Lifetec

- Shenzhen Haibin Pharmaceutical

- Sterile India

- Zhejiang Jiuzhou Pharmaceutical

- Kyongbo Pharm

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Research Report 2021

Table of Contents
1 Antibiotics Active Pharmaceutical Ingredient (API) Market Overview
1.1 Product Overview and Scope of Antibiotics Active Pharmaceutical Ingredient (API)
1.2 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Type
1.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Penicillin Antibiotics
1.2.3 Cephalosporins
1.2.4 Carbapenem Antibiotics
1.3 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Application
1.3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Comparison by Application: (2021-2027)
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organizations (CMOs)
1.3.4 Contract Development & Manufacturing Organizations (CDMOs)
1.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Estimates and Forecasts
1.4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue 2016-2027
1.4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales 2016-2027
1.4.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Antibiotics Active Pharmaceutical Ingredient (API) Market Competition by Manufacturers
2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Sites, Area Served, Product Type
2.5 Antibiotics Active Pharmaceutical Ingredient (API) Market Competitive Situation and Trends
2.5.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibiotics Active Pharmaceutical Ingredient (API) Players Market Share by Revenue
2.5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario by Region
3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.3.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
3.3.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.4.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
3.4.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Region
3.5.1 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region
3.5.2 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.6.1 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
3.6.2 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
3.7.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Analysis by Type
4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)
4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2016-2021)
4.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type (2016-2021)
5 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Analysis by Application
5.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)
5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2016-2021)
5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sandoz International
6.1.1 Sandoz International Corporation Information
6.1.2 Sandoz International Description and Business Overview
6.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.1.5 Sandoz International Recent Developments/Updates
6.2 Centrient Pharmaceuticals
6.2.1 Centrient Pharmaceuticals Corporation Information
6.2.2 Centrient Pharmaceuticals Description and Business Overview
6.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.2.5 Centrient Pharmaceuticals Recent Developments/Updates
6.3 CordenPharma International
6.3.1 CordenPharma International Corporation Information
6.3.2 CordenPharma International Description and Business Overview
6.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.3.5 CordenPharma International Recent Developments/Updates
6.4 ACS DOBFAR
6.4.1 ACS DOBFAR Corporation Information
6.4.2 ACS DOBFAR Description and Business Overview
6.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.4.5 ACS DOBFAR Recent Developments/Updates
6.5 Nanjing Dorra Pharmaceutical Technology
6.5.1 Nanjing Dorra Pharmaceutical Technology Corporation Information
6.5.2 Nanjing Dorra Pharmaceutical Technology Description and Business Overview
6.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.5.5 Nanjing Dorra Pharmaceutical Technology Recent Developments/Updates
6.6 DAEWOONG PHARMACEUTICAL
6.6.1 DAEWOONG PHARMACEUTICAL Corporation Information
6.6.2 DAEWOONG PHARMACEUTICAL Description and Business Overview
6.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.6.5 DAEWOONG PHARMACEUTICAL Recent Developments/Updates
6.7 Parabolic Drugs
6.6.1 Parabolic Drugs Corporation Information
6.6.2 Parabolic Drugs Description and Business Overview
6.6.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.7.5 Parabolic Drugs Recent Developments/Updates
6.8 Penam Laboratories
6.8.1 Penam Laboratories Corporation Information
6.8.2 Penam Laboratories Description and Business Overview
6.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.8.5 Penam Laboratories Recent Developments/Updates
6.9 ASIATIC DRUGS & PHARMACEUTICALS
6.9.1 ASIATIC DRUGS & PHARMACEUTICALS Corporation Information
6.9.2 ASIATIC DRUGS & PHARMACEUTICALS Description and Business Overview
6.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.9.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Developments/Updates
6.10 Fresenius Kabi
6.10.1 Fresenius Kabi Corporation Information
6.10.2 Fresenius Kabi Description and Business Overview
6.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.10.5 Fresenius Kabi Recent Developments/Updates
6.11 The United Laboratories International Holdings
6.11.1 The United Laboratories International Holdings Corporation Information
6.11.2 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.11.5 The United Laboratories International Holdings Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.12.3 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Unimark Remedies
6.13.1 Unimark Remedies Corporation Information
6.13.2 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.13.5 Unimark Remedies Recent Developments/Updates
6.14 Savior Lifetec
6.14.1 Savior Lifetec Corporation Information
6.14.2 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.14.5 Savior Lifetec Recent Developments/Updates
6.15 Shenzhen Haibin Pharmaceutical
6.15.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.15.2 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.15.3 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.15.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.16 Sterile India
6.16.1 Sterile India Corporation Information
6.16.2 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.16.3 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.16.5 Sterile India Recent Developments/Updates
6.17 Zhejiang Jiuzhou Pharmaceutical
6.17.1 Zhejiang Jiuzhou Pharmaceutical Corporation Information
6.17.2 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.17.3 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.17.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
6.18 Kyongbo Pharm
6.18.1 Kyongbo Pharm Corporation Information
6.18.2 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.18.3 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.18.5 Kyongbo Pharm Recent Developments/Updates
7 Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Cost Analysis
7.1 Antibiotics Active Pharmaceutical Ingredient (API) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibiotics Active Pharmaceutical Ingredient (API)
7.4 Antibiotics Active Pharmaceutical Ingredient (API) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibiotics Active Pharmaceutical Ingredient (API) Distributors List
8.3 Antibiotics Active Pharmaceutical Ingredient (API) Customers
9 Antibiotics Active Pharmaceutical Ingredient (API) Market Dynamics
9.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Trends
9.2 Antibiotics Active Pharmaceutical Ingredient (API) Growth Drivers
9.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Challenges
9.4 Antibiotics Active Pharmaceutical Ingredient (API) Market Restraints
10 Global Market Forecast
10.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Type (2022-2027)
10.2 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Application (2022-2027)
10.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) Comparison by Application (2021-2027)
Table 3. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Covered in This Study
Table 5. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) of Key Manufacturers (2016-2021)
Table 6. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antibiotics Active Pharmaceutical Ingredient (API) Average Price (US$/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Sites and Area Served
Table 11. Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibiotics Active Pharmaceutical Ingredient (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotics Active Pharmaceutical Ingredient (API) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021) & (Tons)
Table 16. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2021)
Table 17. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)
Table 19. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)
Table 20. North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)
Table 22. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)
Table 23. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)
Table 24. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021) & (Tons)
Table 27. Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)
Table 31. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)
Table 32. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)
Table 35. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)
Table 38. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) by Type (2016-2021)
Table 39. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)
Table 40. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Share by Type (2016-2021)
Table 42. Global Antibiotics Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Type (2016-2021)
Table 43. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) by Application (2016-2021)
Table 44. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)
Table 45. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Share by Application (2016-2021)
Table 47. Global Antibiotics Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Application (2016-2021)
Table 48. Sandoz International Corporation Information
Table 49. Sandoz International Description and Business Overview
Table 50. Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 51. Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 52. Sandoz International Recent Developments/Updates
Table 53. Centrient Pharmaceuticals Corporation Information
Table 54. Centrient Pharmaceuticals Description and Business Overview
Table 55. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 56. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 57. Centrient Pharmaceuticals Recent Developments/Updates
Table 58. CordenPharma International Corporation Information
Table 59. CordenPharma International Description and Business Overview
Table 60. CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 61. CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 62. CordenPharma International Recent Developments/Updates
Table 63. ACS DOBFAR Corporation Information
Table 64. ACS DOBFAR Description and Business Overview
Table 65. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 66. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 67. ACS DOBFAR Recent Developments/Updates
Table 68. Nanjing Dorra Pharmaceutical Technology Corporation Information
Table 69. Nanjing Dorra Pharmaceutical Technology Description and Business Overview
Table 70. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 71. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 72. Nanjing Dorra Pharmaceutical Technology Recent Developments/Updates
Table 73. DAEWOONG PHARMACEUTICAL Corporation Information
Table 74. DAEWOONG PHARMACEUTICAL Description and Business Overview
Table 75. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 76. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 77. DAEWOONG PHARMACEUTICAL Recent Developments/Updates
Table 78. Parabolic Drugs Corporation Information
Table 79. Parabolic Drugs Description and Business Overview
Table 80. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 81. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 82. Parabolic Drugs Recent Developments/Updates
Table 83. Penam Laboratories Corporation Information
Table 84. Penam Laboratories Description and Business Overview
Table 85. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 86. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 87. Penam Laboratories Recent Developments/Updates
Table 88. ASIATIC DRUGS & PHARMACEUTICALS Corporation Information
Table 89. ASIATIC DRUGS & PHARMACEUTICALS Description and Business Overview
Table 90. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 91. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 92. ASIATIC DRUGS & PHARMACEUTICALS Recent Developments/Updates
Table 93. Fresenius Kabi Corporation Information
Table 94. Fresenius Kabi Description and Business Overview
Table 95. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 96. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 97. Fresenius Kabi Recent Developments/Updates
Table 98. The United Laboratories International Holdings Corporation Information
Table 99. The United Laboratories International Holdings Description and Business Overview
Table 100. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 101. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 102. The United Laboratories International Holdings Recent Developments/Updates
Table 103. Aurobindo Pharma Corporation Information
Table 104. Aurobindo Pharma Description and Business Overview
Table 105. Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 106. Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 107. Aurobindo Pharma Recent Developments/Updates
Table 108. Unimark Remedies Corporation Information
Table 109. Unimark Remedies Description and Business Overview
Table 110. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 111. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 112. Unimark Remedies Recent Developments/Updates
Table 113. Savior Lifetec Corporation Information
Table 114. Savior Lifetec Description and Business Overview
Table 115. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 116. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 117. Savior Lifetec Recent Developments/Updates
Table 118. Shenzhen Haibin Pharmaceutical Corporation Information
Table 119. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 120. Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 121. Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 122. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 123. Sterile India Corporation Information
Table 124. Sterile India Description and Business Overview
Table 125. Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 126. Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 127. Sterile India Recent Developments/Updates
Table 128. Zhejiang Jiuzhou Pharmaceutical Corporation Information
Table 129. Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
Table 130. Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 131. Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 132. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
Table 133. Kyongbo Pharm Corporation Information
Table 134. Kyongbo Pharm Description and Business Overview
Table 135. Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 136. Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 137. Kyongbo Pharm Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Antibiotics Active Pharmaceutical Ingredient (API) Distributors List
Table 141. Antibiotics Active Pharmaceutical Ingredient (API) Customers List
Table 142. Antibiotics Active Pharmaceutical Ingredient (API) Market Trends
Table 143. Antibiotics Active Pharmaceutical Ingredient (API) Growth Drivers
Table 144. Antibiotics Active Pharmaceutical Ingredient (API) Market Challenges
Table 145. Antibiotics Active Pharmaceutical Ingredient (API) Market Restraints
Table 146. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Type (2022-2027) & (Tons)
Table 147. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Type (2022-2027)
Table 148. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 149. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Type (2022-2027)
Table 150. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Application (2022-2027) & (Tons)
Table 151. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Application (2022-2027)
Table 152. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 153. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share Foreca
  • (Post-pandemic Era) - Global Vinpocetine Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 93
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Vinpocetine growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regio......
  • (Post-pandemic Era) - Global Vinpocetine Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Vinpocetine Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 112
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Vaccine Adjuvants Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 85
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Vaccine Adjuvants growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related......
  • (Post-pandemic Era) - Global Vaccine Adjuvants Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 109
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Vaccine Adjuvants Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 109
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Saffron Extract Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Saffron Extract Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 110
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Saffron Extract Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 12-Apr-2021        Price: US 3160 Onwards        Pages: 98
    Summary At the time of this report, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial chain. Faced with the global industrial change in the post epidemic era, enterprises in var......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs